Drug Discovery

Certara and DMTC announce research collaboration to study preventative use of chloroquine in health care workers at high risk for Covid-19

Certara, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical countermeasure capabilities, have entered into a research collaboration to evaluate the preventative use of chloroquine in health care workers at risk of infection from the novel coronavirus strain that causes Covid-19.